FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to pharmacogenetics, and can be used for differentiated choice of pharmacotherapy of arterial hypertension with underlying dorsopathy in operators. Pharmacogenetic testing of cytochrome P 450 CYP2C9 gene is performed. If genotypes CYP2C9*1/*2 or *2/*2 are detected for the treatment of arterial hypertension, Lozartan is used in dosage of 50 mg a day, pain syndrome is relieved by administering Meloxicam 15 mg a day in tablet form for 20 days. If observing the CYP2C9*1/*1 genotype, Amlodipine in dosage of 5 mg a day in a tablet form and Diclofenac in dosage of 75-100 mg/day in a tablet form are prescribed for 20 days.
EFFECT: method provides improved occupationally significant functions in operators with arterial hypertension with underlying dorsopathy due to differentiated choice of pharmacotherapy based on pharmacogenetic testing of cytochrome P 450 CYP2C9 gene.
1 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SELECTION OF PERINDOPRIL DOSAGE FORPATIENTS WITH ISCHEMIC HEART DISEASE ON BACKGROUND OF ARTERIAL HYPERTENSION | 2016 |
|
RU2642284C1 |
| METHOD FOR IMPROVING DRUG USE SAFETY IN TREATING PATIENTS WITH ALCOHOL WITHDRAWAL SYNDROME | 2018 |
|
RU2690522C1 |
| METHOD OF TREATING ESSENTIAL ARTERIAL HYPERTENSION IN ADOLESCENTS WITH OBSTRUCTIVE SLEEP APNOEA/HYPNOEA SYNDROME | 2011 |
|
RU2472535C1 |
| METHOD OF DIFFERENTIATED ADMINISTRATION OF MOXONIDINE IN PATIENTS WITH ARTERIAL HYPERTENSION AT BACKGROUND OF METABOLIC SYNDROME | 2010 |
|
RU2426543C1 |
| METHOD FOR CHOOSING STARTING ANALGESIC DRUGS IN THE POSTOPERATIVE PERIOD AFTER CARDIAC SURGERY | 2021 |
|
RU2774227C1 |
| METHOD FOR PREVENTION OF DEVELOPING CEREBRAL DISORDERS AND CARDIOVASCULAR COMPLICATIONS ACCOMPANYING PRE-HYPERTENSION | 2013 |
|
RU2515482C1 |
| METHOD OF SECONDARY PREVENTION OF ARTERIAL HYPERTENSION OF I-II DEGREE IN SANATORIUM-AND-HEALTH-RESORT CONDITIONS | 2019 |
|
RU2716752C1 |
| METHOD FOR TREATING PATIENTS WITH ISCHEMIC CARDIAC DISEASE, STABLE STENOCARDIA IN COMBINATION WITH ARTERIAL HYPERTENSION | 2005 |
|
RU2294741C1 |
| REMEDY FOR CORRECTING INCREASED METEOROLOGICAL AND MAGNETIC SENSITIVITY IN PATIENTS WITH ARTERIAL HYPERTENSION | 2021 |
|
RU2769686C1 |
| METHOD OF TREATING PATIENTS WITH CARDIOVASCULAR DISEASES | 2013 |
|
RU2543468C2 |
